Stock Price
43.73
Daily Change
-0.31 -0.69%
Monthly
12.50%
Yearly
4.38%
Q1 Forecast
43.53

Qiagen NV reported $216.84M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
IQVIA Holdings USD 170.3M 300K Sep/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Qiagen NV USD 216.84M 7K Sep/2025
Revvity USD 116.07M 258K Sep/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025